SEROWON 250 (Salmeterol (25mcg) + Fluticasone Propionate (250mcg))

SEROWON 250 Inhaler is designed as a combination therapy that facilitates the opening of airways, thus easing the process of breathing. This inhaler is indicated for managing conditions such as asthma, characterized by symptoms like wheezing and shortness of breath, as well as chronic obstructive pulmonary disease (COPD), a condition that impedes airflow in the lungs. It is important to adhere to the usage instructions provided by your healthcare professional, who will clarify the appropriate frequency of inhaler use. Users may start to experience therapeutic benefits within several days, though it may take several weeks for the full effects to manifest. Consistent use is crucial for achieving desired results, even in the absence of symptoms. Discontinuing the inhaler without medical advice could exacerbate asthma or COPD symptoms. SEROWON 250 Inhaler is not intended for immediate relief of acute asthma episodes. In case of such an event, a fast-acting inhaler should be utilized. Proper inhalation technique is vital for optimizing the efficacy of this medication; incorrect usage may lead to suboptimal results. Common side effects may include nausea, vomiting, respiratory infections, oral fungal infections, headaches, changes in voice, sore throat, coughing, musculoskeletal discomfort, and an increased heart rate. If side effects occur, it is vital to maintain the prescribed regimen and consult a healthcare provider for guidance. To mitigate some side effects, it is advisable to rinse the mouth or brush teeth after use. Patients should also be proactive about avoiding asthma triggers and refraining from smoking. Prior to initiating treatment, consult your healthcare provider regarding the safety of using this inhaler during pregnancy or while breastfeeding, and inform them of any existing kidney or liver conditions to ensure appropriate dosing.